Related by context. Frequent words. (Click for all words.) 64 2 methoxyestradiol 63 neovascular 63 Daclizumab 63 Onconase 63 Panzem R 63 proteasome inhibitor 62 refractory chronic lymphocytic 62 Completes Patient Enrollment 62 Initiates Phase II 62 denufosol tetrasodium 62 Panzem R NCD 62 Panzem 62 liposomal formulation 61 geographic atrophy 61 iSONEP 61 factor VIIa 61 Ophthotech 61 Meets Primary Endpoint 61 Factor VIIa 61 Aplidin 61 Xanafide 61 Unit Dose Budesonide 61 Drug Candidate 61 histone deacetylase HDAC inhibitor 60 Receives Orphan Drug Designation 60 bevasiranib 60 Romidepsin 60 squalamine 60 candidate AP# 60 R sorafenib tablets 60 peripherally acting 60 concerning CombinatoRx 60 Corlux 60 diabetic gastroparesis 60 vinblastine 60 inflammation autoimmune diseases 59 BZL# 59 neovascular age 59 JAK inhibitor 59 topical non steroidal 59 AzaSite Plus 59 Soliris TM eculizumab 59 Zoraxel 59 Pimavanserin 59 GSK# [002] 59 novel orally administered 59 Initiate Phase 59 Pivotal Phase III 59 Trofex 59 inflammatory autoimmune diseases 59 metastatic colorectal 59 topical anti infective 59 oral squamous cell 59 ® bortezomib 59 candidate ridaforolimus 59 RhuDex ® 58 Nexavar sorafenib 58 KRN# 58 selectively induce apoptosis 58 central retinal vein 58 gets USFDA nod 58 lung pancreatic 58 Benign Prostatic Hyperplasia 58 C. pneumoniae 58 personalized immunotherapy 58 IMC #F# 58 Aliskiren 58 TELINTRA 58 fibrotic diseases 58 Paraplatin 58 active cellular immunotherapy 58 MKC# 58 Darinaparsin 58 Peyronie Disease 58 Eculizumab 58 Inhalation Aerosol 58 epothilones 58 Phase IIb clinical trials 58 lysosomal storage disorder 58 Degeneration AMD 58 treat gastrointestinal disorders 57 Kinase Inhibitor 57 VEGFR2 inhibitor 57 ALN TTR# 57 Onalta 57 CMV vaccine 57 Omigard TM 57 TRAIL receptor antibodies 57 chemotherapy induced neutropenia 57 Mipomersen 57 gastro intestinal disorders 57 huC# DM4 57 phase IIb clinical 57 Thiarabine 57 organ transplant rejection 57 nitric oxide donating 57 systemically administered 57 Kuvan R 57 Fibrillex TM 57 FluCide 57 Completes Enrollment